Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Transgender Persons | 2 | 2020 | 322 | 0.77 | Why? |
| Bradycardia | 1 | 2020 | 292 | 0.63 | Why? |
| Body Temperature | 1 | 2020 | 875 | 0.56 | Why? |
| Seroconversion | 2 | 2020 | 2515 | 0.51 | Why? |
| Heart Rate | 1 | 2020 | 1527 | 0.43 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.38 | Why? |
| HIV Infections | 3 | 2020 | 11620 | 0.31 | Why? |
| Dideoxynucleosides | 1 | 2020 | 92 | 0.21 | Why? |
| HLA-DRB1 Chains | 1 | 2021 | 196 | 0.20 | Why? |
| Emtricitabine | 1 | 2020 | 202 | 0.20 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.19 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2020 | 139 | 0.19 | Why? |
| Lamivudine | 1 | 2020 | 210 | 0.19 | Why? |
| Antiprotozoal Agents | 1 | 2019 | 83 | 0.19 | Why? |
| Sweet Syndrome | 1 | 2019 | 54 | 0.19 | Why? |
| Toxoplasmosis | 1 | 2019 | 59 | 0.18 | Why? |
| Oxazines | 1 | 2020 | 279 | 0.18 | Why? |
| Hepatitis A | 1 | 2020 | 140 | 0.18 | Why? |
| Adenine | 1 | 2020 | 463 | 0.17 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2020 | 275 | 0.17 | Why? |
| Piperazines | 1 | 2020 | 445 | 0.17 | Why? |
| False Negative Reactions | 2 | 2020 | 1785 | 0.16 | Why? |
| Tenofovir | 1 | 2020 | 449 | 0.16 | Why? |
| Intestinal Obstruction | 1 | 2019 | 197 | 0.16 | Why? |
| Myelodysplastic Syndromes | 1 | 2019 | 261 | 0.15 | Why? |
| Hepatectomy | 1 | 2018 | 276 | 0.14 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.14 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.13 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.12 | Why? |
| Japan | 3 | 2020 | 6653 | 0.12 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Sexual and Gender Minorities | 1 | 2020 | 1019 | 0.10 | Why? |
| Mesenteric Veins | 1 | 2008 | 60 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.09 | Why? |
| Anti-HIV Agents | 1 | 2020 | 2209 | 0.08 | Why? |
| Gastrectomy | 1 | 2008 | 225 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2019 | 1884 | 0.07 | Why? |
| Middle Aged | 7 | 2020 | 270681 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Adult | 5 | 2020 | 244371 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Stomach Neoplasms | 1 | 2008 | 477 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Male | 8 | 2020 | 367725 | 0.06 | Why? |
| X-Ray Microtomography | 1 | 2021 | 115 | 0.06 | Why? |
| Lymph Nodes | 1 | 2008 | 1060 | 0.06 | Why? |
| Immunoglobulin Class Switching | 1 | 2021 | 133 | 0.05 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Therapeutic Irrigation | 1 | 2020 | 167 | 0.05 | Why? |
| Humans | 14 | 2021 | 930598 | 0.05 | Why? |
| Decompression, Surgical | 1 | 2019 | 114 | 0.04 | Why? |
| Tokyo | 1 | 2020 | 645 | 0.04 | Why? |
| Female | 6 | 2020 | 380317 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Aged | 4 | 2020 | 215776 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Gene Frequency | 1 | 2021 | 1210 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Mouthwashes | 1 | 2020 | 432 | 0.04 | Why? |
| Alleles | 1 | 2021 | 1557 | 0.04 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| HIV | 1 | 2020 | 1116 | 0.03 | Why? |
| Specimen Handling | 2 | 2020 | 6190 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Homosexuality, Male | 1 | 2020 | 1158 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Genotype | 1 | 2021 | 4697 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Lymphatic Metastasis | 1 | 2008 | 537 | 0.02 | Why? |
| Lymph Node Excision | 1 | 2008 | 362 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.02 | Why? |
| Medical Records | 1 | 2008 | 513 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Neoplasm Staging | 1 | 2008 | 1999 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2008 | 9537 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
Adachi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(112)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(138)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_